Chris Wasden

Consultant / Advisor at

37celsius Capital Partners LLC

Consumer Services

Finance

Health Technology

Profile

Chris Wasden is currently an Advisory Board member at 37celsius Capital Partners LLC.
He was previously the CEO and President of Tympany, Inc. in 2005, Chairman and CEO of SimplexityMD, Inc. in 2006, and a Thought Leader at GEN3 Partners, Inc. in 2001.
Wasden received his undergraduate degree from Brigham Young University in 1985, his MBA from Anderson School of Management in 1987, and his doctorate from George Washington University in 2009.

Chris Wasden active positions

Companies	Position	Start
37celsius Capital Partners LLC 37celsius Capital Partners LLC Investment ManagersFinance 37celsius Capital Partner invests in companies across the globe primarily in North America with USD 5 - 50 million in revenue. The firm focuses on healthcare technology, services and data. It participates in growth and buyout transactions with investment size ranging from USD 20 - 50 million. It also takes controlling interest.	Consultant / Advisor	-

All active positions of Chris Wasden

Former positions of Chris Wasden

Companies	Position	End
SimplexityMD, Inc. SimplexityMD, Inc. Investment ManagersFinance SimplexityMD focuses on investments in the life science technology sector with emphasis diagnostic and medical devices and tools (DMT). Within the DMT sector, the firm focuses on the aesthetics, cardiovascular and orthopedics areas. They invest primarily in companies located in the Houston, Texas metropolitan area. SimplexityMD typically invests up to $3 million per company. The firm prefers to make controlling investments and to take seats on their portfolio companies' boards of directors. SimplexityMD usually exits their investments within 5 to 7 years.	Corporate Officer/Principal	01/01/2006
Tympany, Inc. Tympany, Inc. Medical SpecialtiesHealth Technology Manufactures advanced digital hearing aids	President	29/09/2005
GEN3 Partners, Inc. GEN3 Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Provides world-class product, process and packaging innovation services	Corporate Officer/Principal	29/04/2001

See the detail of Chris Wasden's experience

Training of Chris Wasden

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chris Wasden's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
George Washington University George Washington University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tympany, Inc. Tympany, Inc. Medical SpecialtiesHealth Technology Manufactures advanced digital hearing aids	Health Technology
Brigham Young University Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
GEN3 Partners, Inc. GEN3 Partners, Inc. Miscellaneous Commercial ServicesCommercial Services Provides world-class product, process and packaging innovation services	Commercial Services
SimplexityMD, Inc. SimplexityMD, Inc. Investment ManagersFinance SimplexityMD focuses on investments in the life science technology sector with emphasis diagnostic and medical devices and tools (DMT). Within the DMT sector, the firm focuses on the aesthetics, cardiovascular and orthopedics areas. They invest primarily in companies located in the Houston, Texas metropolitan area. SimplexityMD typically invests up to $3 million per company. The firm prefers to make controlling investments and to take seats on their portfolio companies' boards of directors. SimplexityMD usually exits their investments within 5 to 7 years.	Finance
Anderson School of Management Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
37celsius Capital Partners LLC 37celsius Capital Partners LLC Investment ManagersFinance 37celsius Capital Partner invests in companies across the globe primarily in North America with USD 5 - 50 million in revenue. The firm focuses on healthcare technology, services and data. It participates in growth and buyout transactions with investment size ranging from USD 20 - 50 million. It also takes controlling interest.	Finance